JP2024546201A5 - - Google Patents
Info
- Publication number
- JP2024546201A5 JP2024546201A5 JP2024533818A JP2024533818A JP2024546201A5 JP 2024546201 A5 JP2024546201 A5 JP 2024546201A5 JP 2024533818 A JP2024533818 A JP 2024533818A JP 2024533818 A JP2024533818 A JP 2024533818A JP 2024546201 A5 JP2024546201 A5 JP 2024546201A5
- Authority
- JP
- Japan
- Prior art keywords
- mass
- pharmaceutical composition
- composition according
- canister
- difluoroethane
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR2113999A FR3130554B1 (fr) | 2021-12-20 | 2021-12-20 | Composition pharmaceutique comprenant du salbutamol |
| FR2113999 | 2021-12-20 | ||
| PCT/FR2022/052421 WO2023118717A1 (fr) | 2021-12-20 | 2022-12-19 | Composition pharmaceutique comprenant du salbutamol |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024546201A JP2024546201A (ja) | 2024-12-18 |
| JP2024546201A5 true JP2024546201A5 (enExample) | 2025-12-04 |
Family
ID=80595325
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024533818A Pending JP2024546201A (ja) | 2021-12-20 | 2022-12-19 | サルブタモールを含む医薬組成物 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250041244A1 (enExample) |
| EP (1) | EP4452227B1 (enExample) |
| JP (1) | JP2024546201A (enExample) |
| CN (1) | CN118510492A (enExample) |
| AU (1) | AU2022420913A1 (enExample) |
| CA (1) | CA3238932A1 (enExample) |
| FR (1) | FR3130554B1 (enExample) |
| MX (1) | MX2024006942A (enExample) |
| WO (1) | WO2023118717A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20250281404A1 (en) * | 2024-03-07 | 2025-09-11 | Recipharm Laboratories, Inc. | Composition for use in pressurised dispensing container |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007020204A2 (en) * | 2005-08-12 | 2007-02-22 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Hfc solution formulations for inhalation containing salbutamol hydrochloride or salbutamol citrate |
| GB201117621D0 (en) | 2011-10-12 | 2011-11-23 | Mexichem Amanco Holding Sa | Compositions |
| GB201117619D0 (en) | 2011-10-12 | 2011-11-23 | Mexichem Amanco Holding Sa | Compositions |
| GB201306984D0 (en) | 2013-04-17 | 2013-05-29 | Mexichem Amanco Holding Sa | Composition |
| GB2573297A (en) * | 2018-04-30 | 2019-11-06 | Mexichem Fluor Sa De Cv | Pharmaceutical composition |
-
2021
- 2021-12-20 FR FR2113999A patent/FR3130554B1/fr active Active
-
2022
- 2022-12-19 CA CA3238932A patent/CA3238932A1/fr active Pending
- 2022-12-19 EP EP22847581.0A patent/EP4452227B1/fr active Active
- 2022-12-19 MX MX2024006942A patent/MX2024006942A/es unknown
- 2022-12-19 JP JP2024533818A patent/JP2024546201A/ja active Pending
- 2022-12-19 WO PCT/FR2022/052421 patent/WO2023118717A1/fr not_active Ceased
- 2022-12-19 AU AU2022420913A patent/AU2022420913A1/en active Pending
- 2022-12-19 CN CN202280081939.8A patent/CN118510492A/zh active Pending
- 2022-12-19 US US18/719,982 patent/US20250041244A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007520508A5 (enExample) | ||
| CA2496699A1 (en) | Pharmaceutical products and compositions comprising specific anticholinergic agents, beta-2 agonists and corticosteroids | |
| JP2018199684A5 (enExample) | ||
| RU2008129600A (ru) | Комбинация и фармацевтический препарат для лечения воспалительных заболеваний | |
| CN1341017A (zh) | 用于治疗气喘的福莫特罗和糖酸莫米松的组合 | |
| JP2008540563A5 (enExample) | ||
| HRP20130835T1 (hr) | Farmaceutske formulacije otopine za davanje kao stlaäśeni inhalat u inhalatoru | |
| CA2550841A1 (en) | Novel combination of anticholinergic and .beta. mimetics for the treatment of respiratory diseases | |
| RU2010108640A (ru) | Новая комбинация терапевтических агентов | |
| JP2005532988A5 (enExample) | ||
| CN111936124A (zh) | 一种含格隆铵盐及茚达特罗盐的气雾剂药物组合物及其制备方法与应用 | |
| JP2022513566A5 (enExample) | ||
| JP2013507429A5 (enExample) | ||
| JP2015504051A5 (enExample) | ||
| JP2024546201A5 (enExample) | ||
| CN106488770A (zh) | 用于治疗copd的福莫特罗和布地奈德的组合 | |
| US20130125882A1 (en) | Method and composition for treating asthma and copd | |
| JP2020516689A5 (enExample) | ||
| JP2008516991A5 (enExample) | ||
| US20140342001A1 (en) | Medicaments | |
| HRP20160630T1 (hr) | Farmaceutske aerosolne formulacije formoterola i beklometazon-dipropionata | |
| BR112023001689A2 (pt) | Terapia de combinação para administração por inalação | |
| JP2021521280A5 (enExample) | ||
| MXPA04007294A (es) | Composicion para inhalacion. | |
| CN118510492A (zh) | 包含沙丁胺醇的药物组合物 |